VALHI INC /DE/ VHI

Healthcare SIC 2810 - Industrial Inorganic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing derived NYSE

Last close 14.32 2026-10-23
Market cap $405.6M 2026-06-30 share count
52-week range 11.44 - 19.19

Valuation FY2025 figures against the last close

P/S0.2x
P/E—
P/FCF—
EV/EBITDA6.4x
Dividend yield2.2%
Diluted EPS-2.02

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Chemicals
  • Component products
  • Real estate management and development
Revenue by segment, 3 categories over 3 years. The same figures are in the table below. FY2025 Chemicals, FY2025: 1.9B (89.5%) 90% Chemicals Component products, FY2025: 158.3M (7.6%) 8% Real estate management and development, FY2025: 59.3M (2.9%) FY2024 Chemicals, FY2024: 1.9B (89.7%) 90% Component products, FY2024: 145.9M (6.9%) 7% Real estate management and development, FY2024: 71.8M (3.4%) FY2023 Chemicals, FY2023: 1.7B (86.7%) 87% Component products, FY2023: 161.3M (8.4%) 8% Real estate management and development, FY2023: 93.9M (4.9%) 5%
Segment FY2025FY2024FY2023
Chemicals $1.86B $1.89B $1.67B
Component products $158.3M $145.9M $161.3M
Real estate management and development $59.3M $71.8M $93.9M

As the company reported it, from the “Business and geographic segments - Segment Operating Performance (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.08B$2.10B$1.92B$2.22B$2.30B$1.85B$1.90B$1.82B$1.88B$1.52B
Cost of revenue $1.78B$1.68B$1.68B$1.73B$1.72B$1.44B$1.46B$1.21B$1.27B$1.21B
Gross profit $295.4M$424.5M$245.2M$490.4M$580.2M$412.1M$434.6M$609.2M$612.9M$307.9M
R&D $17.0M$14.0M$18.0M$16.0M$17.0M$16.0M$17.0M$16.0M$19.0M$13.0M
SG&A $312.3M$256.2M$277.4M$304.0M$311.9M$283.6M$294.2M$310.0M$262.6M$232.6M
Total operating expenses $2.18B$1.92B$2.00B$2.10B$2.08B$1.78B$1.83B$1.65B$1.61B$1.52B
Operating income $63.3M$210.7M$34.2M$239.4M$318.6M$186.1M$192.7M$370.7M$380.3M$119.2M
Interest expense $57.1M$49.9M$28.3M$27.9M$32.5M$36.2M$40.8M$55.7M$58.9M$58.1M
Pre-tax income -$43.0M$244.2M-$19.5M$169.9M$257.8M$100.6M$104.7M$236.2M$291.8M$39.6M
Income tax $11.9M$82.9M$24.6M$36.8M$60.1M$15.9M$26.5M$30.7M$120.0M$18.6M
Net income -$57.6M$108.0M-$9.9M$87.2M$127.2M$55.2M$49.2M$262.2M$207.5M-$15.9M
EPS, basic -2.023.79-0.353.064.461.941.73———
EPS, diluted -2.023.79-0.353.064.461.941.739.200.61-0.05
Shares, diluted (wtd. avg.) 2828282828.5M28.5M28.5M———

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $214.0M$348.3M$407.0M$478.5M$698.4M$518.6M$523.8M$499.8M$435.7M$159.7M
Short-term investments $2.9M$1.9M$56.1M$75.1M$2.6M$4.4M$2.1M$2.5M$3.0M—
Inventory $659.8M$685.8M$596.1M$640.8M$458.7M$538.2M$522.1M$515.8M$398.4M$359.2M
Total current assets $1.26B$1.45B$1.48B$1.59B$1.67B$1.45B$1.43B$1.41B$1.26B$837.4M
Property, plant and equipment $751.6M$723.4M$517.3M$523.8M$563.6M$590.4M$563.0M$563.5M$588.7M$516.0M
Goodwill $382.3M$382.3M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M
Total assets $2.63B$2.80B$2.74B$2.84B$3.01B$2.89B$2.79B$2.71B$2.91B$2.44B
Accounts payable $231.3M$250.0M$228.5M$199.4M$152.7M$117.6M$144.7M$111.5M$116.1M$92.8M
Total current liabilities $449.3M$643.8M$507.1M$492.8M$463.5M$318.1M$322.5M$351.0M$331.1M$294.1M
Retained earnings $508.0M$574.7M$475.8M$482.3M$401.1M$282.9M$239.4M$220.3M-$17.9M-$198.5M
Total equity $1.02B$1.04B$1.28B$1.32B$1.17B$1.01B$980.1M$989.0M$766.7M$444.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$35.5M$44.0M$3.9M$34.9M$459.7M$152.2M$177.2M$165.5M$259.3M$79.8M
Capital expenditure $46.6M$30.9M$48.5M$67.6M$64.1M$65.5M$59.9M$61.4M$71.3M$58.9M
Investing cash flow -$47.8M-$125.0M-$29.0M-$146.7M-$37.4M-$57.0M-$50.7M-$57.0M-$74.4M-$61.6M
Financing cash flow -$71.1M-$2.3M-$75.9M-$114.0M-$189.1M-$122.5M-$64.1M-$59.8M$93.6M-$45.5M
Dividends paid $9.1M$9.1M$9.1M$9.0M$9.0M$13.6M$27.1M$27.1M$27.2M$27.1M
Buybacks ——$2.9M$4.0M$1.5M$1.0M$3.1M———

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-025847.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B 0 1B 2B 3B Revenue, FY2016: 1.5B Gross profit, FY2016: 307.9M Net income, FY2016: -15.9M Revenue, FY2017: 1.9B Gross profit, FY2017: 612.9M Net income, FY2017: 207.5M Revenue, FY2018: 1.8B Gross profit, FY2018: 609.2M Net income, FY2018: 262.2M Revenue, FY2019: 1.9B Gross profit, FY2019: 434.6M Net income, FY2019: 49.2M Revenue, FY2020: 1.8B Gross profit, FY2020: 412.1M Net income, FY2020: 55.2M Revenue, FY2021: 2.3B Gross profit, FY2021: 580.2M Net income, FY2021: 127.2M Revenue, FY2022: 2.2B Gross profit, FY2022: 490.4M Net income, FY2022: 87.2M Revenue, FY2023: 1.9B Gross profit, FY2023: 245.2M Net income, FY2023: -9.9M Revenue, FY2024: 2.1B Gross profit, FY2024: 424.5M Net income, FY2024: 108M Revenue, FY2025: 2.1B Gross profit, FY2025: 295.4M Net income, FY2025: -57.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.52B $1.88B $1.82B $1.90B $1.85B $2.30B $2.22B $1.92B $2.10B $2.08B
Gross profit $307.9M $612.9M $609.2M $434.6M $412.1M $580.2M $490.4M $245.2M $424.5M $295.4M
Net income -$15.9M $207.5M $262.2M $49.2M $55.2M $127.2M $87.2M -$9.9M $108.0M -$57.6M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2810

TickerCompanyMarket capP/ERevenue growth
LIN LINDE PLC $234.56B 34.8x 3.0%
APD Air Products & Chemicals, Inc. $68.40B — -0.5%
MTX MINERALS TECHNOLOGIES INC $1.96B — -2.2%
KRO KRONOS WORLDWIDE INC $900.1M — -1.5%
LXU LSB INDUSTRIES, INC. $712.1M 29.1x 17.8%
TROX Tronox Holdings plc $552.6M — -5.7%
LXFR LUXFER HOLDINGS PLC $462.4M 61.7x -1.9%
NL NLI HOLDINGS, INC. $328.6M — 8.5%